22NW LP
Q4 2024 Form 13-F
SEATTLE, WASHINGTON
CIK 0001694297
· CRD 230788
· SEC-registered investment adviser
$158.5M Reported Value Total
22NW, LP reports 1 total accounts under management (AUM). There are 1 discretionary accounts valued at $261,149,617, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Private funds (Form ADV)
1 fund
· $295.6M gross asset value
Hedge Fund: $295.6M
Source: Form ADV filed 2026-03-13
Reported value
$158.5M
Quarter over quarter
+12.9%
Holdings
16
Top-10 concentration
93.1%
Key People
Form ADV owners & control persons
Aron Reid English
LIMITED PARTNER
James Paul Stoner
CFO, CCO
Filing Navigation
13F Metrics
Loading 13F Metrics
Q4 2024 13F record
Q4 2024 13F filing summary
| Period of report | December 31, 2024 |
|---|---|
| Filed | February 14, 2025 |
| Form | 13F-HR |
| Reported value | $158.5M |
| Positions | 16 |
| Change in reported value | +32.9% |
| New positions | 4 |
| Exited positions | 1 |
| Position turnover | 29.4% |
| Top-10 concentration | 93.1% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2026 13F
Filed Nov 13, 2026
|
15 | $144.3M |
|
Q2 2026 13F
Filed Aug 14, 2026
|
14 | $104.7M |
|
Q1 2026 13F
Filed May 15, 2026
|
16 | $145.9M |
|
Q4 2025 13F
Filed Feb 13, 2026
|
20 | $237.6M |
|
Q3 2025 13F
Filed Nov 14, 2025
|
21 | $212.3M |
|
Q2 2025 13F
Filed Aug 14, 2025
|
21 | $158.8M |
|
Q1 2025 13F
Filed May 14, 2025
|
20 | $149.1M |
|
Q4 2024 13F
Filed Feb 14, 2025
|
16 | $158.5M |
|
Q3 2024 13F
Filed Nov 14, 2024
|
13 | $119.3M |
|
Q2 2024 13F
Filed Aug 14, 2024
|
13 | $117.2M |
|
Q1 2024 13F
Filed May 15, 2024
|
13 | $116.1M |
|
Q4 2023 13F
Filed Feb 14, 2024
|
14 | $153.5M |
|
Q3 2023 13F
Filed Nov 14, 2023
|
13 | $140.3M |
|
Q2 2023 13F
Filed Aug 14, 2023
|
13 | $160.1M |
|
Q1 2023 13F
Filed May 15, 2023
|
16 | $162.7M |
|
Q4 2022 13F
Filed Feb 10, 2023
|
19 | $185.2M |
|
Q3 2022 13F
Filed Nov 14, 2022
|
20 | $176.8M |
|
Q2 2022 13F
Filed Aug 12, 2022
|
20 | $188.4M |
|
Q1 2022 13F
Filed May 13, 2022
|
25 | $275.4M |
|
Q4 2021 13F
Filed Feb 14, 2022
|
25 | $323.4M |
20 earlier quarters on file — choose one from the quarter menu above.
Top 16 holdings · Q4 2024
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | FSTR FOSTER L B CO | $35.3M | 22.28% |
| 2 | LFCR LIFECORE BIOMEDICAL INC | $31.1M | 19.65% |
| 3 | ANEB ANEBULO PHARMACEUTICALS INC | $26.0M | 16.39% |
| 4 | STRL STERLING INFRASTRUCTURE INC | $16.8M | 10.6% |
| 5 | BBSI BARRETT BUSINESS SVCS INC | $11.5M | 7.26% |
| 6 | CULP CULP INC | $9.5M | 6.02% |
| 7 | PFX PHENIXFIN CORP | $5.9M | 3.74% |
| 8 | DHX DHI GROUP INC | $4.6M | 2.91% |
| 9 | FARM FARMER BROS CO | $3.5M | 2.22% |
| 10 | MTW MANITOWOC CO INC | $3.3M | 2.05% |
| 11 | LNTH LANTHEUS HLDGS INC | $3.1M | 1.95% |
| 12 | SRI STONERIDGE INC | $2.1M | 1.36% |
| 13 | NKTR NEKTAR THERAPEUTICS | $2.0M | 1.29% |
| 14 | SSKN STRATA SKIN SCIENCES INC | $1.6M | 0.98% |
| 15 | UFI UNIFI INC | $1.5M | 0.92% |
| 16 | PMDI PSYCHEMEDICS CORPORATION CMN | $618.3K | 0.39% |
Values as reported on the Q4 2024 Form 13F. Every position is in the holdings table below.